Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open-label Study of Seraph 100 in Patients With Prolonged COVID (PC)

NCT06637800 is registered in ClinicalTrials.gov with ExThera Medical Corporation as lead sponsor.

NCT NCT06637800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06637800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open-label Study of Seraph 100 in Patients With Prolonged COVID (PC)
Lead sponsor
ExThera Medical Corporation
Phase
Not applicable
Overall status
Withdrawn
Start date
February 15, 2025
Completion date
April 30, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long covid